Role of LFA-1 and ICAM-1 in Cancer
AbstractThe lymphocyte function-associated antigen-1 (LFA-1) (also known as CD11a/CD18 and αLβ2), is just one of many integrins in the human body, but its significance is derived from its exclusive presence in leukocytes. In this review, we summarize the studies relating LFA-1 and its major ligand ICAM-1 (or CD54) with cancer, through the function of lymphocytes and myeloid cells on tumor cells. We consider how LFA-1 mediates the interaction of leukocytes with tumors and the role of ICAM-1 in tumor dynamics, which can be independent of its interaction with LFA-1. We also offer a more detailed examination of the role of LFA-1 within B-cell chronic lymphocytic leukemia. Finally, we discuss the role that exosomes harboring LFA-1 play in tumor growth and metastasis. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Reina, M.; Espel, E. Role of LFA-1 and ICAM-1 in Cancer. Cancers 2017, 9, 153.
Reina M, Espel E. Role of LFA-1 and ICAM-1 in Cancer. Cancers. 2017; 9(11):153.Chicago/Turabian Style
Reina, Manuel; Espel, Enric. 2017. "Role of LFA-1 and ICAM-1 in Cancer." Cancers 9, no. 11: 153.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.